Literature DB >> 16570191

Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: Another genetic hit in the Mediterranean.

Natalia Cannelli1, Denise Cassandrini, Enrico Bertini, Pasquale Striano, Lucia Fusco, Roberto Gaggero, Nicola Specchio, Roberta Biancheri, Federico Vigevano, Claudio Bruno, Alessandro Simonati, Federico Zara, Filippo M Santorelli.   

Abstract

Neuronal ceroid lipofuscinoses (NCLs) are autosomal recessive neurodegenerative disorders typically characterized by the accumulation of autofluorescent material in tissues. On the basis of clinical features, age at onset, and molecular genetic defects, it is possible to distinguish at least nine forms. The CLN8 form was first described in Finland, where all the patients are homozygous for a p.Arg24Gly mutation in CLN8. More recently, it has been found that a subset of a Turkish variant of late infantile NCL (v-LINCL) is also associated with CLN8 mutations. To identify the molecular defect in Italian patients with v-LINCL, the CLN8 gene was directly sequenced in 10 patients. Controls were screened by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Five fluorescent-labeled microsatellite markers covering 1 cM around the gene were used for haplotype analysis. In three Italian v-LINCL patients, identified in a small area in southern Italy, we detected four new mutations in CLN8: c.66delG (p.Gly22fs), c.88G>C (p.Ala30Pro), c.473A>G (p.Tyr158Cys), and c.581A>G (p.Gln194Arg). The single-base deletion was found in two unrelated patients. The novel missense mutations were not identified in ethnically matched control chromosomes. Our findings expand the number of CLN8 variants and corroborate the notion that CLN8 patients are not confined to the Finnish population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570191     DOI: 10.1007/s10048-005-0024-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  17 in total

Review 1.  The neuronal ceroid-lipofuscinoses.

Authors:  Matti Haltia
Journal:  J Neuropathol Exp Neurol       Date:  2003-01       Impact factor: 3.685

Review 2.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

3.  Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.

Authors:  W A Mitchell; R B Wheeler; J D Sharp; S L Bate; R M Gardiner; U S Ranta; L Lonka; R E Williams; A E Lehesjoki; S E Mole
Journal:  Eur J Paediatr Neurol       Date:  2001       Impact factor: 3.140

4.  The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum.

Authors:  L Lonka; A Kyttälä; S Ranta; A Jalanko; A E Lehesjoki
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

5.  Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis.

Authors:  R Herva; J Tyynelä; A Hirvasniemi; M Syrjäkallio-Ylitalo; M Haltia
Journal:  Brain Pathol       Date:  2000-04       Impact factor: 6.508

6.  A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis.

Authors:  Martin L Katz; Shahnawaz Khan; Tomoyuki Awano; S Adam Shahid; Aristotle N Siakotos; Gary S Johnson
Journal:  Biochem Biophys Res Commun       Date:  2005-02-11       Impact factor: 3.575

7.  Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.

Authors:  Meral Topçu; Hüseyin Tan; Dilek Yalnizoğlu; Alp Usubütün; Işil Saatçi; Müjgan Aynaci; Banu Anlar; Haluk Topaloğlu; Güzide Turanli; Gülşen Köse; Sabiha Aysun
Journal:  Turk J Pediatr       Date:  2004 Jan-Mar       Impact factor: 0.552

Review 8.  Current state of clinical and morphological features in human NCL.

Authors:  Hans H Goebel; Krystyna E Wisniewski
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

9.  Neuronal ceroid-lipofuscinoses in Italy: an epidemiological study.

Authors:  F Cardona; E Rosati
Journal:  Am J Med Genet       Date:  1995-06-05

Review 10.  The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.

Authors:  Jill M Weimer; Elizabeth Kriscenski-Perry; Yasser Elshatory; David A Pearce
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 4.103

View more
  14 in total

Review 1.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

2.  The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.

Authors:  Shaho Parvin; Maryam Rezazadeh; Hassan Hosseinzadeh; Mohsen Moradi; Shadi Shiva; Jalal Gharesouran
Journal:  Neuromolecular Med       Date:  2019-03-27       Impact factor: 3.843

3.  The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter.

Authors:  Eija Siintola; Meral Topcu; Nina Aula; Hannes Lohi; Berge A Minassian; Andrew D Paterson; Xiao-Qing Liu; Callum Wilson; Ulla Lahtinen; Anna-Kaisa Anttonen; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2007-05-14       Impact factor: 11.025

Review 4.  Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.

Authors:  Amanda L Getty; David A Pearce
Journal:  Cell Mol Life Sci       Date:  2010-08-01       Impact factor: 9.207

5.  CLN8 disease caused by large genomic deletions.

Authors:  Clare Beesley; Rita J Guerreiro; Jose T Bras; Ruth E Williams; Ana Lia Taratuto; Christin Eltze; Sara E Mole
Journal:  Mol Genet Genomic Med       Date:  2016-11-23       Impact factor: 2.183

6.  Atypical presentation of neuronal ceroid lipofuscinosis type 8 in a sibling pair and review of the eye findings and neurological features.

Authors:  Rossana L Sanchez; Jiong Yan; Sarah Richards; Gary Mierau; Eric P Wartchow; Christin D Collins; Suma P Shankar
Journal:  Am J Ophthalmol Case Rep       Date:  2016-08-27

7.  CLN8 Mutations Presenting with a Phenotypic Continuum of Neuronal Ceroid Lipofuscinosis-Literature Review and Case Report.

Authors:  Magdalena Badura-Stronka; Anna Winczewska-Wiktor; Anna Pietrzak; Adam Sebastian Hirschfeld; Tomasz Zemojtel; Katarzyna Wołyńska; Katarzyna Bednarek-Rajewska; Monika Seget-Dubaniewicz; Agnieszka Matheisel; Anna Latos-Bielenska; Barbara Steinborn
Journal:  Genes (Basel)       Date:  2021-06-23       Impact factor: 4.096

8.  Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy.

Authors:  Filippo Maria Santorelli; Barbara Garavaglia; Francesco Cardona; Nardo Nardocci; Bernardo Dalla Bernardina; Stefano Sartori; Agnese Suppiej; Enrico Bertini; Dianela Claps; Roberta Battini; Roberta Biancheri; Mirella Filocamo; Francesco Pezzini; Alessandro Simonati
Journal:  Orphanet J Rare Dis       Date:  2013-02-02       Impact factor: 4.123

9.  Genome-wide association study reveals genetic architecture of eating behavior in pigs and its implications for humans obesity by comparative mapping.

Authors:  Duy Ngoc Do; Anders Bjerring Strathe; Tage Ostersen; Just Jensen; Thomas Mark; Haja N Kadarmideen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

10.  AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.

Authors:  Tyler B Johnson; Katherine A White; Jon J Brudvig; Jacob T Cain; Logan Langin; Melissa A Pratt; Clarissa D Booth; Derek J Timm; Samantha S Davis; Brandon Meyerink; Shibi Likhite; Kathrin Meyer; Jill M Weimer
Journal:  Mol Ther       Date:  2020-09-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.